Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women

Journal of the American Heart Association

Volumn 4, Issue 10, 2015, Pages

  Hodson, Leanne ^a   Banerjee, Rajarshi ^b   Rial, Belen ^b   Arlt, Wiebke ^c   Adiels, Martin ^d   Boren, Jan ^d   Marinou, Kyriakoula ^a,e   Fisher, Ciaran ^f   Mostad, Ingrid L ^g,h   Stratton, Irene M ⁱ   Barrett, P Hugh R ^j,k   Chan, Dick C ^j   Watts, Gerald F ^j   Harnden, Karin ^a   Karpe, Fredrik ^a,l   Fielding, Barbara A ^a,f  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f UNIVERSITY OF SURREY   (United Kingdom)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

ⁱ CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

more..

Author keywords

Apolipoproteins; Cholesterol; Lipids; Lipoproteins; Menopause; Women

Indexed keywords

APOLIPOPROTEIN B; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100; APOLIPOPROTEIN C3; FATTY ACID; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; FATTY ACID DESATURATION; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FEMALE; HUMAN; LIPID METABOLISM; LIPOGENESIS; NORMAL HUMAN; PARTICLE SIZE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; HYPERLIPIDEMIAS; KINETICS; LIVER; METABOLISM; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; WEIGHT GAIN;

ADIPOSITY; ADULT; AGED; APOLIPOPROTEIN B-100; APOLIPOPROTEIN C-III; FATTY ACIDS; FEMALE; HUMANS; HYPERLIPIDEMIAS; KINETICS; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEINS, VLDL; LIVER; MIDDLE AGED; OBESITY, ABDOMINAL; OXIDATION-REDUCTION; PARTICLE SIZE; POSTMENOPAUSE; PREMENOPAUSE; TRIGLYCERIDES; WEIGHT GAIN;

EID: 85006223091     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002258     Document Type: Article

References (51)

1. Ng MK. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease. Heart Lung Circ. 2007;16:185-192.
2. Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metabolism. 1997;46:5-9.
3. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404-2411.
4. Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan RS, O''Donnell CJ, Fox CS. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care. 2009;32:481-485.
5. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92:3490-3497.
6. Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PH. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism. 2002;51:1041-1046.
7. Zheng C, Khoo C, Furtado J, Sacks FM. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation. 2010;121:1722-1734.
8. Meigs JB, Wilson PW, Nathan DM, D-Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
9. Karpe F, Bell M, Bjorkegren J, Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol. 1995;15:199-207.
10. Adiels M, Olofsson SO, Taskinen MR, Boren J. Overproduction of very lowdensity lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225-1236.
11. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755-765.
12. Vice E, Privette JD, Hickner RC, Barakat HA. Ketone body metabolism in lean and obese women. Metabolism. 2005;54:1542-1545.
13. Hodson L, Bickerton AS, McQuaid SE, Roberts R, Karpe F, Frayn KN, Fielding BA. The contribution of splanchnic fat to VLDL triglyceride is greater in insulinresistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes. 2007;56:2433-2441.
14. Hodson L, McQuaid SE, Humphreys SM, Milne R, Fielding BA, Frayn KN, Karpe F. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation? Am J Physiol Endocrinol Metab. 2010;299:E584-E592.
15. Hodson L, Harnden K, Banerjee R, Real B, Marinou K, Karpe F, Fielding BA. Lower resting and total energy expenditure in post-menopausal compared with pre-menopausal women matched for abdominal obesity. J Nutr Sci. 2014;3:9.
16. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062.
17. British Heart Foundation. Available at: http://www.bhf.org.uk/. Accessed April 1, 2007.
18. Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S. Multiparametric magnetic resonance for the noninvasive diagnosis of liver disease. J Hepatol. 2014;60:69-77.
19. Diraison F, Pachiaudi C, Beylot M. Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom. 1997;32:81-86.
20. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br J Nutr. 2011;105:857-865.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
22. O-Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, Stewart PM, Tomlinson JW, Arlt W. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014;99:1027-1036.
23. Adiels M, Packard C, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Taskinen MR, Boren J. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J Lipid Res. 2005;46:58-67.
24. Sarac I, Backhouse K, Shojaee-Moradie F, Stolinski M, Robertson MD, Bell JD, Thomas EL, Hovorka R, Wright J, Umpleby AM. Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men. J Clin Endocrinol Metab. 2012;97:2475-2481.
25. Chan DC, Nguyen MN, Watts GF, Barrett PH. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J Clin Endocrinol Metab. 2008;93:557-564.
26. Hodson L, Fielding BA. Stearoyl-CoA desaturase: rogue or innocent bystander? Prog Lipid Res. 2013;52:15-42.
27. Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P, Soos MA, Carpenter TA, Lomas DJ, Cochran EK, Gorden P, O-Rahilly S, Savage DB. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119:315-322.
28. Moore JB, Gunn PJ, Fielding BA. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients. 2014;6:5679-5703.
29. Krzywinski M, Birol I, Jones SJ, Marra MA. Hive plots-rational approach to visualizing networks. Brief Bioinform. 2012;13:627-644.
30. Magkos F, Patterson BW, Mittendorfer B. Reproducibility of stable isotopelabeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res. 2007;48:1204-1211.
31. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab. 2007;92:1311-1318.
32. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 2009;106: 15430-15435.
33. Nielsen S, Karpe F. Determinants of VLDL-triglycerides production. Curr Opin Lipidol. 2012;23:321-326.
34. Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis. 2004;176:49-56.
35. Mittendorfer B, Patterson BW, Klein S. Effect of weight loss on VLDLtriglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab. 2003;284:E549-E556.
36. Mittendorfer B, Patterson BW, Klein S, Sidossis LS. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab. 2003;284:E708-E715.
37. Gormsen LC, Nellemann B, Sorensen LP, Jensen MD, Christiansen JS, Nielsen S. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab. 2009;296:E165-E173.
38. Nordestgaard BG, Tybjaerg-Hansen A. IDL, VLDL, chylomicrons and atherosclerosis. Eur J Epidemiol. 1992;8(suppl 1):92-98.
39. Gaw A, Packard CJ, Lindsay GM, Griffin BA, Caslake MJ, Lorimer AR, Shepherd J. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. J Lipid Res. 1995;36:158-171.
40. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDLtriacylglycerol kinetics. Am J Clin Nutr. 2003;77:573-579.
41. Smith GI, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B. Systemic delivery of estradiol, but not testosterone or progesterone, alters VLDLtriglyceride kinetics in postmenopausal women. J Clin Endocrinol Metab. 2014;99:E1306-E1310.
42. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366-2373.
43. Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol. 1994;266:E914-E920.
44. McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, Ruge T, Gilbert M, Fielding BA, Frayn KN, Karpe F. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes. 2011;60:47-55.
45. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes. 2011;60:2441-2449.
46. Vedala A, Wang W, Neese RA, Christiansen MP, Hellerstein MK. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J Lipid Res. 2006;47:2562-2574.
47. Matikainen N, Adiels M, Soderlund S, Stennabb S, Ahola T, Hakkarainen A, Boren J, Taskinen MR. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins. Obesity (Silver Spring). 2014;22:1854-1859.
48. Pedersen SB, Jonler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab. 1994;78:1354-1359.
49. Larsson CA, Gullberg B, Rastam L, Lindblad U. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a crosssectional study. BMC Endocr Disord. 2009;9:16.
50. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it-s not just about sex hormones. J Clin Endocrinol Metab. 2011;96:885-893.
51. Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010;375:1634-1639.